Inflammation in preterm birth: Novel mechanism of preterm birth associated with innate and acquired immunity.


Journal

Journal of reproductive immunology
ISSN: 1872-7603
Titre abrégé: J Reprod Immunol
Pays: Ireland
ID NLM: 8001906

Informations de publication

Date de publication:
12 2022
Historique:
received: 07 06 2022
revised: 26 08 2022
accepted: 11 09 2022
pubmed: 21 9 2022
medline: 1 12 2022
entrez: 20 9 2022
Statut: ppublish

Résumé

Preterm birth (PB) is the most-frequent complication occurring during pregnancy, with a significant impact on neonatal morbidity and mortality. Chorioamnionitis (CAM), the neutrophil infiltration into chorioamniotic membranes, is a major cause of PB. However, several cases of PB have also been reported without apparent pathogenic infection or CAM. Such cases are now attributed to "sterile inflammation." The concept of sterile inflammation has already attracted attention in various diseases, like cardiovascular diseases, diabetes, and autoimmune diseases; recently been discussed for obstetric complications such as miscarriage, PB, gestational hypertension, and gestational diabetes. Sterile inflammation is induced by alarmins, such as high-mobility group box 1 (HMGB1), interleukins (IL-33 and IL-1α), and S100 proteins, that are released by cellular damage without apparent pathogenic infection. These antigens are recognized by pattern-recognition receptors, expressed mainly on antigen-presenting cells of decidua, placenta, amnion, and myometrium, which consequently trigger inflammation. In reproduction, these alarmins are associated with the development of various pregnancy complications, including PB. In this review, we have summarized the development of PB related to acute CAM, chronic CAM, and sterile inflammation as well as proposed a new mechanism for PB that involves innate immunity, acquired immunity, and sterile inflammation.

Identifiants

pubmed: 36126439
pii: S0165-0378(22)00277-7
doi: 10.1016/j.jri.2022.103748
pii:
doi:

Substances chimiques

Alarmins 0

Types de publication

Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103748

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Yasuyuki Negishi (Y)

Department of Microbiology and Immunology, Nippon Medical School, Tokyo, Japan; Department of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan. Electronic address: negi@nms.ac.jp.

Yoshio Shima (Y)

Department of Pediatrics, Nippon Medical School Musashikosugi Hospital, Kanagawa, Japan. Electronic address: shima-p@nms.ac.jp.

Masahiko Kato (M)

Department of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan. Electronic address: m-kato@nms.ac.jp.

Tomoko Ichikawa (T)

Department of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan. Electronic address: prima@nms.ac.jp.

Hajime Ino (H)

Department of Microbiology and Immunology, Nippon Medical School, Tokyo, Japan; Department of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan. Electronic address: h-ino@nms.ac.jp.

Yumi Horii (Y)

Department of Microbiology and Immunology, Nippon Medical School, Tokyo, Japan; Department of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan. Electronic address: kiyo-7135109@nms.ac.jp.

Shunji Suzuki (S)

Department of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan. Electronic address: shun@nms.ac.jp.

Rimpei Morita (R)

Department of Microbiology and Immunology, Nippon Medical School, Tokyo, Japan. Electronic address: rimpei-morita@nms.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH